BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

South Korea · Delayed Price · Currency is KRW

11,700

-520 (-4.26%)

At close: Oct 21, 2026

Market Cap	172.61B -25.6%
Revenue (ttm)	28.56B -16.0%
Net Income	6.52B -16.6%
EPS	428.59 -32.2%
Shares Out	14.75M
PE Ratio	27.30
Forward PE	n/a
Dividend	100.00 (0.85%)
Ex-Dividend Date	Dec 29, 2025

Volume	69,304
Open	11,850
Previous Close	12,220
Day's Range	11,350 - 12,190
52-Week Range	5,230 - 16,090
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About BIOBIJOU

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia,... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2018

Employees 42

Stock Exchange KOSDAQ

Ticker Symbol 489460

Full Company Profile

Financial Performance

In 2025, BIOBIJOU's revenue was 28.49 billion, a decrease of -3.86% compared to the previous year's 29.63 billion. Earnings were 4.15 billion, a decrease of -42.24%.

Financial Statements